Cargando…

Effects of Qili Qiangxin Capsule on AQP2, V2R, and AT1R in Rats with Chronic Heart Failure

Qili qiangxin capsule (QL), a traditional Chinese herbal compound, has been proved to be effective and safe for the treatment of chronic heart failure (CHF). Upregulation of aquaporin-2 (AQP2) accounts for the water retention in CHF. The aim of the present study was to evaluate the effects of QL on...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cui, Xiangning, Zhang, Jian, Li, Yubo, Sun, Yuxiu, Cao, Jian, Zhao, Mingjing, Zhao, Yizhou, Zhao, Xin, He, Yaoyao, Han, Anbang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4449905/ https://www.ncbi.nlm.nih.gov/pubmed/26074997 http://dx.doi.org/10.1155/2015/639450

Ejemplares similares

Beneficial Effects of Qili Qiangxin Capsule on Lung Structural Remodeling in Ischemic Heart Failure via TGF-β1/Smad3 Pathway
por: He, Yaoyao, et al.
Publicado: (2015)

Clinical Effect of Qili Qiangxin Capsule Combined with Sacubitril-Valsartan in Patients with Chronic Heart Failure
por: Yao, Jiafang, et al.
Publicado: (2022)

Qili Qiangxin capsules for chronic heart failure: A GRADE-assessed clinical evidence and preclinical mechanism
por: Xing, Xiaoxiao, et al.
Publicado: (2023)

Retracted: Clinical Effect of Qili Qiangxin Capsule Combined with Sacubitril-Valsartan in Patients with Chronic Heart Failure
por: Healthcare Engineering, Journal of
Publicado: (2023)

Qili Qiangxin Capsule Combined With Sacubitril/Valsartan for HFrEF: A Systematic Review and Meta-Analysis
por: Xiang, Qian, et al.
Publicado: (2022)

Clinical Efficacy of Qili Qiangxin Capsule Combined with Western Medicine in the Treatment of Chronic Heart Failure: A Systematic Review and Meta-Analysis
por: Xu, Xiaoming, et al.
Publicado: (2021)

Potential mechanisms of Qili Qiangxin capsule to prevent pulmonary arterial hypertension based on network pharmacology analysis in a rat model
por: Han, Xiao, et al.
Publicado: (2022)

Efficacy and Safety of Qili Qiangxin Capsule on Dilated Cardiomyopathy: A Systematic Review and Meta-Analysis of 35 Randomized Controlled Trials
por: Wei, Jingjing, et al.
Publicado: (2022)

Clinical effects of a standardized Chinese herbal remedy, Qili Qiangxin, as an adjuvant treatment in heart failure: systematic review and meta-analysis
por: Sun, Jin, et al.
Publicado: (2016)

Traditional Chinese medicine Qili qiangxin inhibits cardiomyocyte apoptosis in rats following myocardial infarction
por: XIAO, JUN, et al.
Publicado: (2015)

Qili Qiangxin (QLQX) capsule as a multi-functional traditional Chinese medicine in treating chronic heart failure (CHF): A review of ingredients, molecular, cellular, and pharmacological mechanisms
por: Wang, Tongxing, et al.
Publicado: (2023)

AVP-Induced Increase in AQP2 and p-AQP2 Is Blunted in Heart Failure during Cardiac Remodeling and Is Associated with Decreased AT1R Abundance in Rat Kidney
por: Lütken, Sophie Constantin, et al.
Publicado: (2015)

Qiliqiangxin Capsule Improves Cardiac Function and Attenuates Cardiac Remodeling by Upregulating miR-133a after Myocardial Infarction in Rats
por: Chen, Huiyang, et al.
Publicado: (2019)

Long-term toxicological studies on the Chinese medicine 2036 Specialty-Qiangxin recipe in rats
por: Zhao, Andong, et al.
Publicado: (2021)

The pathogenesis of idiopathic normal pressure hydrocephalus based on the understanding of AQP1 and AQP4
por: Zhao, Zitong, et al.
Publicado: (2022)

Qiliqiangxin Capsules Optimize Cardiac Metabolism Flexibility in Rats With Heart Failure After Myocardial Infarction
por: Cheng, Wenkun, et al.
Publicado: (2020)

AQP2 Plasma Membrane Diffusion Is Altered by the Degree of AQP2-S256 Phosphorylation
por: Arnspang, Eva C., et al.
Publicado: (2016)

Effects of Shenfu Qiangxin Drink on H(2)O(2)-induced oxidative stress, inflammation and apoptosis in neonatal rat cardiomyocytes and possible underlying mechanisms
por: Zhang, Sujie, et al.
Publicado: (2021)

MiR-877 suppresses gastric cancer progression by downregulating AQP3
por: Zhu, Hongyu, et al.
Publicado: (2020)

Immunohistochemical Localization of the Aquaporins AQP1, AQP3, AQP4, and AQP5 in the Mouse Respiratory System
por: Matsuzaki, Toshiyuki, et al.
Publicado: (2009)

Comparison of different protocols of Morris water maze in cognitive impairment with heart failure
por: Lu, Ziwen, et al.
Publicado: (2020)

RyR2 and Calcium Release in Heart Failure
por: Benitah, Jean-Pierre, et al.
Publicado: (2021)

Aqp5 Is a New Transcriptional Target of Dot1a and a Regulator of Aqp2
por: Wu, Hongyu, et al.
Publicado: (2013)

Abnormalities of hippocampus and frontal lobes in heart failure patients and animal models with cognitive impairment or depression: A systematic review
por: Lu, Ziwen, et al.
Publicado: (2022)

Disruption of Membranes of Extracellular Vesicles Is Necessary for ELISA Determination of Urine AQP2: Proof of Disruption and Epitopes of AQP2 Antibodies
por: Nameta, Masaaki, et al.
Publicado: (2016)

Hyaluronic acid reagent functional chitosan-PEI conjugate with AQP2-siRNA suppressed endometriotic lesion formation
por: Zhao, Meng-Dan, et al.
Publicado: (2016)

The characters of antibodies against PLA2R in healthy individuals and in the patient with PLA2R associated membranous nephropathy
por: Cheng, Yan-jiao, et al.
Publicado: (2023)

AQP1 and AQP4 Contribution to Cerebrospinal Fluid Homeostasis
por: Trillo-Contreras, José Luis, et al.
Publicado: (2019)

(S)-3-Bromo-4-diallylamino-5-[(1R,2S,5R)-2-isopropyl-5-methylcyclohexyloxy]furan-2(5H)-one
por: Fu, Jian-Hua, et al.
Publicado: (2010)

Expression and Significance of AQP3 in Cutaneous Lesions
por: Niu, Dongfeng, et al.
Publicado: (2021)

Correction: The characters of antibodies against PLA2R in healthy individuals and in the patient with PLA2R associated membranous nephropathy
por: Cheng, Yan-jiao, et al.
Publicado: (2023)

Loss of Pten in Renal Tubular Cells Leads to Water Retention by Upregulating AQP2
por: Sun, Zhuo, et al.
Publicado: (2022)

miR-320 accelerates chronic heart failure with cardiac fibrosis through activation of the IL6/STAT3 axis
por: Li, Fang, et al.
Publicado: (2021)

MiR-196b Promotes the Invasion and Migration of Lung Adenocarcinoma Cells by Targeting AQP4
por: Wu, Xuhui, et al.
Publicado: (2021)

Maternal Protein Restriction Differentially Alters the Expression of AQP1, AQP9 and VEGFr-2 in the Epididymis of Rat Offspring
por: Cavariani, Marilia Martins, et al.
Publicado: (2019)

Reduced urinary release of AQP1‐ and AQP2‐bearing extracellular vesicles in patients with advanced chronic kidney disease
por: Oshikawa‐Hori, Sayaka, et al.
Publicado: (2021)

Structural Insights into AQP2 Targeting to Multivesicular Bodies
por: Roche, Jennifer Virginia, et al.
Publicado: (2019)

Correction for: miR-320 accelerates chronic heart failure with cardiac fibrosis through activation of the IL6/STAT3 axis
por: Li, Fang, et al.
Publicado: (2023)

(1R,3S,4R,4aS,7R,7aS,10R,12aR)-3-Azido-4,7,10-trimethyl-1,10-epidioxyperhydropyrano[4,3-j][1,2]benzodioxepine
por: Xie, Lijun, et al.
Publicado: (2010)

(R)-[(R)-3-Benzyl-2-oxooxazolidin-4-yl][4-(methylsulfonyl)phenyl]methyl acetate
por: Li, Feng, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_mo4spvs35apdsv6v9lh3tq8lga